Project documents | Obecabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia [ID6347] | Guidance | NICE

Documents

Documents created during the development process.

Draft guidance

Draft guidance
Draft guidance (downloadable version) (PDF 308 KB)

Published:

13 June 2025
Draft guidance (online commenting)
Committee papers (PDF 10.47 MB)

Published:

13 June 2025
Public committee slides (PDF 676 KB)

Published:

13 June 2025
Equality impact assessment (downloadable version) (PDF 111 KB)

Published:

13 June 2025

Invitation to participate

Final scope (PDF 204 KB)

Published:

05 September 2024
Equality impact assessment (guidance development) (PDF 123 KB)

Published:

05 September 2024
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 258 KB)

Published:

05 September 2024
Final stakeholder list (PDF 185 KB)

Published:

05 September 2024

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6347

Draft scope post referral (PDF 213 KB)

Published:

11 July 2024
Draft matrix post referral (PDF 186 KB)

Published:

11 July 2024